Stay updated on CT-P13 SubQ in Active Crohn's: LIBERTY-CD Clinical Trial

Sign up to get notified when there's something new on the CT-P13 SubQ in Active Crohn's: LIBERTY-CD Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the CT-P13 SubQ in Active Crohn's: LIBERTY-CD Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    Publications section updated with a new 2026 Adv Ther article by Schreiber et al. on symptom response dynamics for personalised subcutaneous infliximab in Crohn's disease. The previous online-ahead-of-print citation was removed and replaced by the formal 2026 publication with an updated Revision: v3.6.3.
    Difference
    0.1%
    Check dated 2026-06-30T00:39:10.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    Recruitment status updated to 'No longer looking for participants,' and new help sections were added (How to Read a Study Record, Common Questions, How to Join a Study). The Interventions label formatting was updated to Intervention/Treatment, accompanied by a revision note for v3.6.0.
    Difference
    0.4%
    Check dated 2026-06-15T19:29:27.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    The page's revision entry was updated to v3.5.5, replacing the previous v3.5.4 entry to reflect a new version of the ClinicalTrials.gov page.
    Difference
    0.0%
    Check dated 2026-06-08T17:12:50.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    The page shows a new Revision: v3.5.4, replacing the previous v3.5.3. This indicates a minor update to the page's build or metadata rather than its content.
    Difference
    0.0%
    Check dated 2026-05-18T03:59:47.000Z thumbnail image
  6. Check
    66 days ago
    Change Detected
    Summary
    The page now includes an additional listed PubMed publication citation about immunogenicity outcomes in subcutaneous infliximab recipients. It also updates the site’s revision/version label from v3.5.0 to v3.5.3.
    Difference
    0.1%
    Check dated 2026-04-26T15:19:23.000Z thumbnail image
  7. Check
    87 days ago
    Change Detected
    Summary
    Added a new PubMed citation to the Publications section: Schreiber S, Sands BE, Danese S, Loftus EV Jr, Jeong AL, Kim DH, Lee YN, Colombel JF. Symptom Response Dynamics for Personalised Therapy with Subcutaneous Infliximab in Crohn's Disease: Insights from the Randomised, Placebo-Controlled, Phase 3 LIBERTY-CD Trial. Adv Ther. 2026 Mar 30. Online ahead of print.
    Difference
    0.0%
    Check dated 2026-04-05T05:55:38.000Z thumbnail image

Stay in the know with updates to CT-P13 SubQ in Active Crohn's: LIBERTY-CD Clinical Trial

Enter your email address, and we'll notify you when there's something new on the CT-P13 SubQ in Active Crohn's: LIBERTY-CD Clinical Trial page.